Completed PHASE4 INTERVENTIONAL 1-arm NCT00202722

Remifentanil as Intravenous Patient-controlled Analgesia (IVPCA) During Labour

Remifentanil as Analgesia for Labour Pain

Sponsor: Sorlandet Hospital HF

Conditions Adverse Effects Labour Pain Satisfaction

Updated 8 times since 2017 Last updated: May 22, 2014 Started: Jan 31, 2004 Primary completion: Jul 31, 2007 Completion: Aug 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Adverse Effects and Labour Pain and is currently completed. Sorlandet Hospital HF leads this study, which shows 8 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sorlandet Hospital HF

Data source: Sorlandet Hospital HF

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kristiansand, Norway